Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > San Diego

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Jan 05, 2024 5:19am

185 Views

Post# 35811941

RE:RE:RE:RE:RE:San Diego

Haha you're validating this "trust me bro" story and want to hear more "trust me bros"? How's about someone repeats the experiment and calls this chap to see if there's any truth to it.

I'd suggest we ask Dude, Johnny or Saxy from Stocktwits if they would be willing. All 3 are fair and reasonable people. Otherwise this is more unsubstantiated nonsense.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season